CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-04 | Montagut Etienne Chief Business Officer | Sale | −12,655 | $57.38 | $726K | 83,975 |
| 2022-03-31 | LENO SAM R Director | Exercise or conversion | +4,448 | $23.04 | $102K | 53,745 |
| 2022-03-31 | LENO SAM R Director | Exercise or conversion · Stock Option (right to buy) | −4,448 | 0 | ||
| 2022-03-30 | Walker Carol Senior Vice President, Quality | Sale | −15,000 | $56.22 | $843K | 64,899 |
| 2022-03-08 | Niedzwiecki Daniel | Sale | −432 | $50.63 | $22K | 72,523 |
| 2022-03-08 | Sabens Andrea Chief Accounting Officer | Sale | −391 | $50.63 | $20K | 65,027 |
| 2022-03-07 | Niedzwiecki Daniel | Sale | −1,330 | $52.55 | $70K | 72,955 |
| 2022-03-07 | Blanchfield Paul Chief Commercial Officer | Sale | −2,228 | $52.55 | $117K | 76,431 |
| 2022-03-07 | Marshall Robert J. Jr. CFO and Treasurer | Sale | −4,380 | $52.55 | $230K | 145,893 |
| 2022-03-07 | Walker Carol Senior Vice President, Quality | Sale | −1,593 | $52.55 | $84K | 79,899 |
| 2022-03-07 | Montagut Etienne Chief Business Officer | Sale | −3,115 | $52.55 | $164K | 96,634 |
| 2022-03-07 | Sabens Andrea Chief Accounting Officer | Sale | −1,228 | $52.55 | $65K | 65,418 |
| 2022-03-04 | Marshall Robert J. Jr. CFO and Treasurer | Sale | −2,570 | $49.98 | $128K | 150,273 |
| 2022-03-04 | Blanchfield Paul Chief Commercial Officer | Sale | −3,914 | $49.98 | $196K | 78,659 |
| 2022-03-04 | Montagut Etienne Chief Business Officer | Sale | −1,635 | $49.98 | $82K | 99,749 |
| 2022-03-04 | Walker Carol Senior Vice President, Quality | Sale | −1,536 | $49.98 | $77K | 81,492 |
| 2022-03-04 | Heino Mary Anne President & CEO | Sale | −697 | $49.96 | $35K | 718,869 |
| 2022-03-04 | Heino Mary Anne President & CEO | Sale | −11,478 | $51.24 | $588K | 707,391 |
| 2022-03-03 | Marshall Robert J. Jr. CFO and Treasurer | Grant or award | +25,911 | 152,843 | ||
| 2022-03-03 | Marshall Robert J. Jr. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +14,773 | 14,773 |
Page 22 of 27 · 534 trades